Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Exact Sciences Corporation    EXAS

EXACT SCIENCES CORPORATION

(EXAS)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 12/02 03:02:25 pm
124.45 USD   +0.99%
11/27EXACT SCIENCES CORP : Other Events (form 8-K)
AQ
11/10EXACT SCIENCES : Code of Business Conduct and Ethics
PU
11/10EXACT SCIENCES : Policy Governing Director Nominations
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Exact Sciences: 2Q Earnings Snapshot

07/30/2020 | 05:21pm EST

MADISON, Wis. (AP) _ Exact Sciences Corp. (EXAS) on Thursday reported a loss of $86.1 million in its second quarter.

The Madison, Wisconsin-based company said it had a loss of 58 cents per share.

The results beat Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 62 cents per share.

The molecular diagnostics company posted revenue of $268.9 million in the period, also beating Street forecasts. Seven analysts surveyed by Zacks expected $229.6 million.

Exact Sciences shares have risen roughly 6% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $97.90, a decline of 17% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EXAS at https://www.zacks.com/ap/EXAS

© 2020 The Canadian Press. All rights reserved., source Canadian Press DataFile

All news about EXACT SCIENCES CORPORATION
11/27EXACT SCIENCES CORP : Other Events (form 8-K)
AQ
11/10EXACT SCIENCES : Code of Business Conduct and Ethics
PU
11/10EXACT SCIENCES : Policy Governing Director Nominations
PU
10/27EXACT SCIENCES : to buy cancer-screening firm Thrive Earlier Detection in $2.15 ..
RE
10/27EXACT SCIENCES : Infographic
PU
10/27EXACT SCIENCES : 3Q Earnings Snapshot
AQ
10/27EXACT SCIENCES : Management's Discussion and Analysis of Financial Condition and..
AQ
10/07PFIZER : Will Continue Helping Exact Sciences With Cologuard Promotion Through 2..
DJ
09/21EXACT SCIENCES CORP : Change in Directors or Principal Officers (form 8-K)
AQ
07/31EXACT SCIENCES : Management's Discussion and Analysis of Financial Condition and..
AQ
More news
Financials (USD)
Sales 2020 1 451 M - -
Net income 2020 -379 M - -
Net cash 2020 182 M - -
P/E ratio 2020 -50,5x
Yield 2020 -
Capitalization 19 597 M 19 597 M -
EV / Sales 2020 13,4x
EV / Sales 2021 10,6x
Nbr of Employees 4 110
Free-Float 99,1%
Chart EXACT SCIENCES CORPORATION
Duration : Period :
Exact Sciences Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EXACT SCIENCES CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 15
Average target price 150,43 $
Last Close Price 123,23 $
Spread / Highest target 30,7%
Spread / Average Target 22,1%
Spread / Lowest Target 13,6%
EPS Revisions
Managers
NameTitle
Kevin T. Conroy Chairman, President & Chief Executive Officer
Ana Hooker Senior Vice President-Operations
Jeffrey Thomas Elliott Chief Financial Officer
Graham Peter Lidgard Chief Science Officer, SVP-Research & Development
Sandra Statz SVP-Clinical & Regulatory Affairs
Sector and Competitors
1st jan.Capitalization (M$)
EXACT SCIENCES CORPORATION33.25%19 597
GUARDANT HEALTH, INC.55.14%12 120
INVITAE CORPORATION211.04%8 865
ADAPTIVE BIOTECHNOLOGIES CORPORATION63.40%6 687
IOVANCE BIOTHERAPEUTICS, INC.49.28%6 061
SEEGENE INC--.--%4 493